The COMCID Study Raises New Questions in Dementia Research
National Cerebral and Cardiovascular Center
The COMCID study is Japan’s first multicenter investigator-initiated clinical trial involving patients with mild cognitive impairment
Neuroscience
Gene Therapy to Treat Rare and Hereditary Diseases
Norwegian University of Science And Technology
Researchers are finding clues that may help treat rare and deadly diseases using mini-organs and advanced technology
Combination Therapy Improves Rare Brain Tumors in Children
Great Ormond Street Hospital
Trials showed the effect of combination therapy on survival and quality of life in children with low- and high-grade gliomas
MS Biomarker Test Gets Breakthrough Device Designation
Swathi Kodaikal, MSc
Blood NfL levels can provide insights into neurological conditions such as Alzheimer’s, Parkison’s, and Huntington’s diseases
World’s First Brain Biobank Accelerates Clinical Research
Swathi Kodaikal, MSc
The CNIO network aims to use patient-derived samples to drive ethical, efficient, and high-precision clinical care
Novel Blood Biomarker Identifies Parkinsonian Diseases Early On
Lund University
DOPA decarboxylase was found elevated many years before individuals developed Parkinson’s symptoms
New Roles of Genes Driving Parkinson’s Onset Discovered
Northwestern University
Scientists report that damage starts much earlier than the death of dopamine neurons
Latest Study Reveals Novel Therapeutic Approach for PTSD
Louisiana State University Health Sciences Center
HCN plasticity may have a direct impact on memory formation and can explored to find treatments for PTSD, memory loss
Largest Study Determines Genetic Factors Associated with Epilepsy
Royal College of Surgeons in Ireland
Identifying epilepsy-associated genetic accelerates the development of treatment options
Plasma Test Screens for Alzheimer’s with Very High Accuracy
University of Gothenburg
The new test employs a two-step workflow to accurately identify or exclude brain amyloidosis in patients with MCI
New Blood Biomarker Aids Early Detection of Parkinson’s
Duke Health
Blood test accurately detects certain genetic mutations in the mitochondrial DNA of patients with Parkinson’s
FDA Approves First Biosimilar to Treat Multiple Sclerosis
U.S. Food and Drug Administration
Tyruko® has been shown to safely mitigate and manage inflammation in autoimmune conditions like Crohn’s disease
Tau-Based Biomarker Tracks Alzheimer’s Progression
Washington University in St. Louis
Novel marker found in cerebrospinal fluid also could speed development of Alzheimer’s drugs
Genetic Markers Exacerbating MS Severity Identified
University of Cambridge
Discovery opens the door to treatments for multiple sclerosis-associated long-term disability
Brain Processes Acute and Chronic Pain Differently: Early Studies
National Institutes of Health
Study shows preliminary results that could lead to new pain treatments and help improve quality of life in individuals
FDA Approves First Drug to Treat Dementia-Associated Agitation in AD Patients
U.S. Food and Drug Administration
Individuals who received two mg or three mg of Rexulti showed statistically significant and clinically meaningful improvements
Structural Variants Contributing to Non-Alzheimer’s Dementia Identified
National Institutes of Health
Discovery provides potential clues for Lewy body and frontotemporal dementias
Genetic Mutations Linked to Temporal Lobe Epilepsy Identified
Mass General Brigham
Findings point to the potential for using existing cancer therapies to treat drug-resistant epilepsy
Brain Networks Involved in Epileptic Seizures Identified
University College London
Surgically disconnecting specific networks in the brain may help patients live epilepsy-free for a longer time
Glycans in Blood May Predict Alzheimer’s Disease
Karolinska Institutet
Patients with matching levels of certain blood glycans and tau protein were over twice as likely to develop Alzheimer’s